MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin

Abstract Diabetic nephropathy is one of the most prevalent chronic complications of Diabetes mellitus, but its pathogenesis remains elusive. This study was designed to determine the role of tristetraprolin (TTP), inflammatory cytokines and microRNAs (miRNAs) in DN. The blood and urine samples were o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jia Guo, Jing Li, Jing Zhao, Shuguang Yang, Luyao Wang, Genyang Cheng, Dong Liu, Jing Xiao, Zhangsuo Liu, Zhanzheng Zhao
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9305eebe24aa4598a0e2461ceefc447b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9305eebe24aa4598a0e2461ceefc447b
record_format dspace
spelling oai:doaj.org-article:9305eebe24aa4598a0e2461ceefc447b2021-12-02T12:31:59ZMiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin10.1038/s41598-017-01027-52045-2322https://doaj.org/article/9305eebe24aa4598a0e2461ceefc447b2017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01027-5https://doaj.org/toc/2045-2322Abstract Diabetic nephropathy is one of the most prevalent chronic complications of Diabetes mellitus, but its pathogenesis remains elusive. This study was designed to determine the role of tristetraprolin (TTP), inflammatory cytokines and microRNAs (miRNAs) in DN. The blood and urine samples were obtained from 32 patients with DN, 33 patients with type 2 DM, and 35 normal healthy subjects as controls. Renal tissue samples were also obtained from 10 DN patients and 10 normal controls. The miRNA microarray analyses were performed in pooled plasma and urine sediment samples of eight DN patients and eight age- and sex-matched health control subjects and three paired renal tissues from patients with DN and normal controls. Conditionally immortalized mouse podocytes (MPC5) were used a cell model. The expressions of TTP and cytokines in patient samples and cultured cells were determined by qRT-PCR and Western blotting or ELISA. Our results indicated that miRNA-29c directly targeted TTP and promoted inflammatory response under hyperglycemic conditions. Overexpression of miRNA-29c in podocytes resulted in an increase in inflammatory cytokines and inhibition of miRNA-29c by using its inhibitor reduced the inflammatory cytokines in podocytes. Finally, miRNA-29c promoted the progression of DN by targeting TTP, providing a target for a therapeutic intervention of DN.Jia GuoJing LiJing ZhaoShuguang YangLuyao WangGenyang ChengDong LiuJing XiaoZhangsuo LiuZhanzheng ZhaoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jia Guo
Jing Li
Jing Zhao
Shuguang Yang
Luyao Wang
Genyang Cheng
Dong Liu
Jing Xiao
Zhangsuo Liu
Zhanzheng Zhao
MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin
description Abstract Diabetic nephropathy is one of the most prevalent chronic complications of Diabetes mellitus, but its pathogenesis remains elusive. This study was designed to determine the role of tristetraprolin (TTP), inflammatory cytokines and microRNAs (miRNAs) in DN. The blood and urine samples were obtained from 32 patients with DN, 33 patients with type 2 DM, and 35 normal healthy subjects as controls. Renal tissue samples were also obtained from 10 DN patients and 10 normal controls. The miRNA microarray analyses were performed in pooled plasma and urine sediment samples of eight DN patients and eight age- and sex-matched health control subjects and three paired renal tissues from patients with DN and normal controls. Conditionally immortalized mouse podocytes (MPC5) were used a cell model. The expressions of TTP and cytokines in patient samples and cultured cells were determined by qRT-PCR and Western blotting or ELISA. Our results indicated that miRNA-29c directly targeted TTP and promoted inflammatory response under hyperglycemic conditions. Overexpression of miRNA-29c in podocytes resulted in an increase in inflammatory cytokines and inhibition of miRNA-29c by using its inhibitor reduced the inflammatory cytokines in podocytes. Finally, miRNA-29c promoted the progression of DN by targeting TTP, providing a target for a therapeutic intervention of DN.
format article
author Jia Guo
Jing Li
Jing Zhao
Shuguang Yang
Luyao Wang
Genyang Cheng
Dong Liu
Jing Xiao
Zhangsuo Liu
Zhanzheng Zhao
author_facet Jia Guo
Jing Li
Jing Zhao
Shuguang Yang
Luyao Wang
Genyang Cheng
Dong Liu
Jing Xiao
Zhangsuo Liu
Zhanzheng Zhao
author_sort Jia Guo
title MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin
title_short MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin
title_full MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin
title_fullStr MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin
title_full_unstemmed MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin
title_sort mirna-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/9305eebe24aa4598a0e2461ceefc447b
work_keys_str_mv AT jiaguo mirna29cregulatestheexpressionofinflammatorycytokinesindiabeticnephropathybytargetingtristetraprolin
AT jingli mirna29cregulatestheexpressionofinflammatorycytokinesindiabeticnephropathybytargetingtristetraprolin
AT jingzhao mirna29cregulatestheexpressionofinflammatorycytokinesindiabeticnephropathybytargetingtristetraprolin
AT shuguangyang mirna29cregulatestheexpressionofinflammatorycytokinesindiabeticnephropathybytargetingtristetraprolin
AT luyaowang mirna29cregulatestheexpressionofinflammatorycytokinesindiabeticnephropathybytargetingtristetraprolin
AT genyangcheng mirna29cregulatestheexpressionofinflammatorycytokinesindiabeticnephropathybytargetingtristetraprolin
AT dongliu mirna29cregulatestheexpressionofinflammatorycytokinesindiabeticnephropathybytargetingtristetraprolin
AT jingxiao mirna29cregulatestheexpressionofinflammatorycytokinesindiabeticnephropathybytargetingtristetraprolin
AT zhangsuoliu mirna29cregulatestheexpressionofinflammatorycytokinesindiabeticnephropathybytargetingtristetraprolin
AT zhanzhengzhao mirna29cregulatestheexpressionofinflammatorycytokinesindiabeticnephropathybytargetingtristetraprolin
_version_ 1718394228775583744